5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
Condition:   Oligometastatic Prostate Cancer Interventions:   Radiation: Hypofractionated external beam radiotherapy;   Radiation: High dose rate brachytherapy;   Radiation: Permanent seed implant;   Radiation: Stereotactic body radiotherapy Sponsor:   British Columbia Cancer Agency Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2020 Category: Research Source Type: clinical trials